Genentech Begins $750M Expansion in Oregon; LNG Contract Secured in British Columbia
1 report, 1 independent
Updated Oct 2
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Genentech, a member of the Hoffmann-La Roche Group, broke ground on a $750 million expansion of its manufacturing campus in Hillsboro, Oregon. This facility addition will increase capacity for advanced drug delivery devices and is scheduled to be operational in 2031. Separately, a Fluor-JCG Joint Venture won a $15 billion LNG contract in British Columbia.
From constructiondive.com
Why it matters
The projects represent significant capital investment in critical infrastructure and pharmaceutical manufacturing capabilities. The expansion leverages the existing U.S. manufacturing push of the Roche Group and secures a major energy infrastructure contract for the involved JV.
From constructiondive.com
Who's involved
- Hoffmann-La RocheThe parent company of Genentech, whose group is driving the U.S. manufacturing investment.
- British ColumbiaThe province where the LNG contract was secured.